Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study.
Hodaka YamadaMasashi YoshidaDaisuke SuzukiShunsuke FunazakiShuichi NagashimaKimura MasahikoOtsuka KiyoshiKazuo HaraPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
This study provided real-world evidence showing that OW semaglutide significantly reduced HbA1c in Japanese patients with T2DM who had inadequate HbA1c control.